{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:42:53Z","timestamp":1790962973278,"version":"4.1.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-67553-1","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:04:41Z","timestamp":1722427481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Multi-epitope peptide vaccines targeting dengue virus serotype 2 created via immunoinformatic analysis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-194X","authenticated-orcid":false,"given":"Radwa N.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser S. M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Y.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7608-850X","authenticated-orcid":false,"given":"Khaled M.","family":"Aboshanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"67553_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23880\/vij-16000301","volume":"6","author":"A Janaki","year":"2022","unstructured":"Janaki, A. Recent trends in Dengue virus infection; An Analysis of virological, clinical and laboratory profiles of patients with Dengue virus infection in the center for clinical management of dengue fever and dengue hemorrhagic fever Sri-Lanka. Virol. Immunol. J. 6, 1\u20138 (2022).","journal-title":"Virol. Immunol. J."},{"issue":"2","key":"67553_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1053\/jinf.2001.0802","volume":"42","author":"T Solomon","year":"2001","unstructured":"Solomon, T. & Mallewa, M. Dengue and other emerging flaviviruses. J. Infect. 42(2), 104\u2013115 (2001).","journal-title":"J. Infect."},{"key":"67553_CR3","first-page":"16","volume":"4","author":"AM Tejo","year":"2024","unstructured":"Tejo, A. M., Hamasaki, D. T., Menezes, L. M. & Ho, Y. L. Severe dengue in the intensive care unit. J. Intensive Care Med. 4, 16\u201333 (2024).","journal-title":"J. Intensive Care Med."},{"issue":"1","key":"67553_CR4","doi-asserted-by":"publisher","first-page":"13496","DOI":"10.1038\/s41598-021-92783-y","volume":"11","author":"SP Yenamandra","year":"2021","unstructured":"Yenamandra, S. P. et al. Evolution, heterogeneity and global dispersal of cosmopolitan genotype of Dengue virus type 2. Sci. Rep. 11(1), 13496 (2021).","journal-title":"Sci. Rep."},{"key":"67553_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40794-023-00188-8","volume":"9","author":"O Dafalla","year":"2023","unstructured":"Dafalla, O. et al. The emergence of an imported variant of dengue virus serotype 2 in the Jazan region, southwestern Saudi Arabia. Trop. Dis. Travel Med. Vaccin. 9, 5 (2023).","journal-title":"Trop. Dis. Travel Med. Vaccin."},{"key":"67553_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.2000.63.5","volume":"63","author":"E Harris","year":"2000","unstructured":"Harris, E. et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63, 5\u201311 (2000).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"67553_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2022.101818","volume":"63","author":"M Shoushtari","year":"2022","unstructured":"Shoushtari, M. et al. Designing vaccine candidates against dengue virus by in silico studies on structural and nonstructural domains. Mol. cell. Probes 63, 101818 (2022).","journal-title":"Mol. cell. Probes"},{"key":"67553_CR8","doi-asserted-by":"publisher","first-page":"110043","DOI":"10.1016\/j.envres.2020.110043","volume":"191","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Effects of ambient temperature and precipitation on the risk of dengue fever: A systematic review and updated meta-analysis. Environ. Res. 191, 110043 (2020).","journal-title":"Environ. Res."},{"issue":"6","key":"67553_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jmii.2020.03.007","volume":"53","author":"WH Wang","year":"2020","unstructured":"Wang, W. H. et al. Dengue hemorrhagic fever\u2014 A systemic literature review of current perspectives on pathogenesis, prevention and control. J. Microbiol. Immunol. Infect. 53(6), 963\u2013978 (2020).","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"1","key":"67553_CR10","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1038\/s41598-022-09489-y","volume":"12","author":"TK Martheswaran","year":"2022","unstructured":"Martheswaran, T. K. et al. Prediction of dengue fever outbreaks using climate variability and Markov chain Monte Carlo techniques in a stochastic susceptible-infected-removed model. Sci. Rep. 12(1), 5459 (2022).","journal-title":"Sci. Rep."},{"issue":"4","key":"67553_CR11","first-page":"279","volume":"14","author":"C de Mendoza","year":"2012","unstructured":"de Mendoza, C. et al. Emerging viral infections\u2013a potential threat for blood supply in the 21st century. AIDS Rev. 14(4), 279\u2013289 (2012).","journal-title":"AIDS Rev."},{"issue":"8","key":"67553_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3201\/eid2808.220550","volume":"28","author":"M Giovanetti","year":"2022","unstructured":"Giovanetti, M. et al. Emergence of Dengue virus serotype 2 Cosmopolitan genotype Brazil. Emerg. Infect. Dis. 28(8), 1725\u20131727 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"67553_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tmaid.2019.04.006","volume":"30","author":"KK Altassan","year":"2019","unstructured":"Altassan, K. K. et al. Dengue fever in Saudi Arabia: A review of environmental and population factors impacting emergence and spread. Travel Med. Infect.Dis. 30, 46\u201353 (2019).","journal-title":"Travel Med. Infect.Dis."},{"issue":"12","key":"67553_CR14","doi-asserted-by":"publisher","first-page":"e0005194","DOI":"10.1371\/journal.pntd.0005194","volume":"10","author":"JM Humphrey","year":"2016","unstructured":"Humphrey, J. M. et al. Dengue in the Middle East and North Africa: A systematic review. PLOS Negl. Trop. Dis. 10(12), e0005194 (2016).","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"6","key":"67553_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/vbz.2015.1911","volume":"16","author":"SA El-Kafrawy","year":"2016","unstructured":"El-Kafrawy, S. A. et al. Multiple introductions of Dengue 2 virus strains into Saudi Arabia from 1992 to 2014. Vector Borne Zoonotic. Dis. 16(6), 391\u2013399 (2016).","journal-title":"Vector Borne Zoonotic. Dis."},{"issue":"11","key":"67553_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.15537\/smj.2021.42.11.20210124","volume":"42","author":"S Melebari","year":"2021","unstructured":"Melebari, S. et al. The epidemiology and incidence of dengue in Makkah, Saudi Arabia, during 2017\u20132019. Saudi Med. J. 42(11), 1173\u20131179 (2021).","journal-title":"Saudi Med. J."},{"key":"67553_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6803098","author":"N Khetarpal","year":"2016","unstructured":"Khetarpal, N. & Khanna, I. Dengue fever: Causes, complications, and vaccine strategies. J. immunol. Res. https:\/\/doi.org\/10.1155\/2016\/6803098 (2016).","journal-title":"J. immunol. Res."},{"issue":"9951","key":"67553_CR18","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384(9951), 1358\u20131365 (2014).","journal-title":"Lancet"},{"issue":"2","key":"67553_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"L Villar","year":"2015","unstructured":"Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N. Engl. J. Med. 372(2), 113\u2013123 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"67553_CR20","doi-asserted-by":"publisher","first-page":"001831","DOI":"10.1099\/jgv.0.001831","volume":"104","author":"J Pintado Silva","year":"2023","unstructured":"Pintado Silva, J. & Fernandez-Sesma, A. Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art. J. Gen. Virol. 104(3), 001831 (2023).","journal-title":"J. Gen. Virol."},{"key":"67553_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro, S. R. et al. Efficacy and long-term safety of a Dengue vaccine in regions of endemic disease. New Eng. J.Med. 373, 1195\u20131206 (2015).","journal-title":"New Eng. J.Med."},{"issue":"3","key":"67553_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40259-022-00531-z","volume":"36","author":"JM Torres-Flores","year":"2022","unstructured":"Torres-Flores, J. M., Reyes-Sandoval, A. & Salazar, M. I. Dengue Vaccines: An Update. BioDrugs 36(3), 325\u2013336 (2022).","journal-title":"BioDrugs"},{"issue":"9853","key":"67553_CR23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","volume":"380","author":"A Sabchareon","year":"2012","unstructured":"Sabchareon, A. et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial. Lancet 380(9853), 1559\u20131567 (2012).","journal-title":"Lancet"},{"key":"67553_CR24","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.tmaid.2023.102598","volume":"54","author":"M Angelin","year":"2023","unstructured":"Angelin, M. et al. Qdenga\u00ae - A promising dengue fever vaccine; Can it be recommended to non-immune travelers?. Travel Med. Infect. Dis. 54, 102598 (2023).","journal-title":"Travel Med. Infect. Dis."},{"key":"67553_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3906\/biy-2006-1","volume":"44","author":"M Topuzo\u011fullari","year":"2020","unstructured":"Topuzo\u011fullari, M. et al. An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19. Turk. J. Biol. 44, 215\u2013227 (2020).","journal-title":"Turk. J. Biol."},{"key":"67553_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1874091X02014010009","volume":"14","author":"AH Alkaff","year":"2020","unstructured":"Alkaff, A. H., Saragih, M., Fardiansyah, M. A. & Tambunan, U. S. F. Role of Immunoinformatics in accelerating epitope-based vaccine development against Dengue virus. Open Biochem. J. 14, 9\u201318 (2020).","journal-title":"Open Biochem. J."},{"issue":"6","key":"67553_CR27","doi-asserted-by":"publisher","first-page":"e00276","DOI":"10.1128\/mBio.00276-11","volume":"2","author":"P Avirutnan","year":"2011","unstructured":"Avirutnan, P. et al. Complement-mediated neutralization of dengue virus requires mannose-binding lectin. mBio 2(6), e00276-e311 (2011).","journal-title":"mBio"},{"issue":"1","key":"67553_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12929-018-0462-0","volume":"25","author":"HR Chen","year":"2018","unstructured":"Chen, H. R., Lai, Y. C. & Yeh, T. M. Dengue virus non-structural protein 1: A pathogenic factor, therapeutic target, and vaccine candidate. J. Biomed. Sci 25(1), 58 (2018).","journal-title":"J. Biomed. Sci"},{"issue":"12","key":"67553_CR29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/vaccines10122028","volume":"10","author":"NL Warner","year":"2022","unstructured":"Warner, N. L., Core, S. B. & Frietze, K. M. Unbiased identification of Dengue virus non-structural protein 1 peptides for use in vaccine design. Vaccines 10(12), 2028 (2022).","journal-title":"Vaccines"},{"issue":"15","key":"67553_CR30","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.vaccine.2023.03.005","volume":"41","author":"N Ikewaki","year":"2023","unstructured":"Ikewaki, N. et al. Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management. Vaccine 41(15), 2427\u20132429 (2023).","journal-title":"Vaccine"},{"key":"67553_CR31","doi-asserted-by":"publisher","first-page":"112304","DOI":"10.1016\/j.biopha.2021.112304","volume":"144","author":"WH Wang","year":"2021","unstructured":"Wang, W. H. et al. Targets and strategies for vaccine development against dengue viruses. Biomed. Pharmacother. 144, 112304 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"67553_CR32","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/v14071452","volume":"14","author":"PBA Pinto","year":"2022","unstructured":"Pinto, P. B. A. et al. Combination of E- and NS1-Derived DNA vaccines the immune response and protection elicited in mice against DENV2. Viruses 14(7), 1452 (2022).","journal-title":"Viruses"},{"key":"67553_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/vim.2012.0063","volume":"26","author":"Y Yin","year":"2013","unstructured":"Yin, Y., Jiang, L., Fang, D., Jiang, L. & Zhou, J. Differentially expressed genes of human microvascular endothelial cells in response to anti-dengue virus NS1 antibodies by suppression subtractive hybridization. Viral Immunol. 26, 185\u2013191 (2013).","journal-title":"Viral Immunol."},{"key":"67553_CR34","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1038\/s41467-018-07667-z","volume":"9","author":"D Jayathilaka","year":"2018","unstructured":"Jayathilaka, D. et al. Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection. Nat. Commun. 9, 5242 (2018).","journal-title":"Nat. Commun."},{"key":"67553_CR35","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3389\/fimmu.2019.02125","volume":"10","author":"Y Tian","year":"2019","unstructured":"Tian, Y., Grifoni, A., Sette, A. & Weiskopf, D. Human T cell response to Dengue virus infection. Front. Immunol. 10, 2125 (2019).","journal-title":"Front. Immunol."},{"key":"67553_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/vaccines9060622","volume":"9","author":"KL Carpio","year":"2021","unstructured":"Carpio, K. L. & Barrett, A. D. T. Flavivirus NS1 and its potential in vaccine development. Vaccines 9, 622 (2021).","journal-title":"Vaccines"},{"key":"67553_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen, M. V. et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinform. 8, 424 (2007).","journal-title":"BMC Bioinform."},{"key":"67553_CR38","doi-asserted-by":"publisher","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","volume":"9","author":"JJA Calis","year":"2013","unstructured":"Calis, J. J. A. et al. Properties of MHC class i presented peptides that enhance immunogenicity. PLoS Comput. Biol. 9, e1003266 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"67553_CR39","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In Silico Approach for predicting toxicity of peptides and proteins. PLoS ONE 8, e73957 (2013).","journal-title":"PLoS ONE"},{"key":"67553_CR40","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","volume":"14","author":"I Dimitrov","year":"2013","unstructured":"Dimitrov, I., Flower, D. R. & Doytchinova, I. AllerTOP\u2014 a server for in silico prediction of allergens. BMC Bioinform. 14, S4 (2013).","journal-title":"BMC Bioinform."},{"key":"67553_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4 (2007).","journal-title":"BMC Bioinform."},{"key":"67553_CR42","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkn254","volume":"36","author":"Q Zhang","year":"2008","unstructured":"Zhang, Q. et al. Immune epitope database analysis resource (IEDB-AR). Nucl. Acids Res. 36, W513\u2013W518 (2008).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR43","doi-asserted-by":"publisher","first-page":"42851","DOI":"10.1038\/srep42851","volume":"7","author":"G Nagpal","year":"2017","unstructured":"Nagpal, G. et al. Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci. Rep. 7, 42851 (2017).","journal-title":"Sci. Rep."},{"key":"67553_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/263952","volume":"2013","author":"SK Dhanda","year":"2013","unstructured":"Dhanda, S. K., Gupta, S., Vir, P. & Raghava, G. P. S. Prediction of IL4 Inducing Peptides. Clin. Dev. Immunol. 2013, 1\u20139 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"67553_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda, S. K., Vir, P. & Raghava, G. P. Designing of interferon-gamma inducing MHC class-II binders. Biol. Direct 8, 30 (2013).","journal-title":"Biol. Direct"},{"key":"67553_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha, S. & Raghava, G. P. S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65, 40\u201348 (2006).","journal-title":"Proteins"},{"key":"67553_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/978-1-60327-118-9_29","volume":"409","author":"S Saha","year":"2007","unstructured":"Saha, S. & Raghava, G. P. Prediction methods for B-cell epitopes. Methods Mol. Biol. 409, 387\u2013394 (2007).","journal-title":"Methods Mol. Biol."},{"key":"67553_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"H-H Bui","year":"2007","unstructured":"Bui, H.-H., Sidney, J., Li, W., Fusseder, N. & Sette, A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform. 8, 361 (2007).","journal-title":"BMC Bioinform."},{"key":"67553_CR49","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547\u20131549 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"67553_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui, H. H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform. 7, 153 (2006).","journal-title":"BMC Bioinform."},{"key":"67553_CR51","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gkad376","volume":"51","author":"J Rey","year":"2023","unstructured":"Rey, J., Murail, S., de Vries, S., Derreumaux, P. & Tuffery, P. PEP-FOLD4: A pH-dependent force field for peptide structure prediction in aqueous solution. Nucl. Acids Res. 51, W432\u2013W437 (2023).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR52","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"N Guex","year":"1997","unstructured":"Guex, N. & Peitsch, M. C. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 18, 2714\u20132723 (1997).","journal-title":"Electrophoresis"},{"key":"67553_CR53","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1128\/JVI.01841-12","volume":"86","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Cross-Allele cytotoxic T Lymphocyte responses against 2009 pandemic H1N1 Influenza A virus among HLA-A24 and HLA-A3 Supertype-positive individuals. J. Virol. 86, 13281\u201313294 (2012).","journal-title":"J. Virol."},{"key":"67553_CR54","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3389\/fimmu.2019.01709","volume":"10","author":"S Zhu","year":"2019","unstructured":"Zhu, S. et al. Divergent peptide presentations of HLA-A*30 alleles revealed by structures with pathogen peptides. Front. Immunol. 10, 1709 (2019).","journal-title":"Front. Immunol."},{"key":"67553_CR55","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.molimm.2013.03.015","volume":"55","author":"L Niu","year":"2013","unstructured":"Niu, L. et al. Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes. Mol. Immunol. 55, 381\u2013392 (2013).","journal-title":"Mol. Immunol."},{"key":"67553_CR56","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s13238-016-0309-y","volume":"7","author":"X Li","year":"2016","unstructured":"Li, X. et al. Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection. Protein cell 7, 761\u2013765 (2016).","journal-title":"Protein cell"},{"key":"67553_CR57","doi-asserted-by":"publisher","first-page":"781","DOI":"10.4049\/jimmunol.1402542","volume":"194","author":"PM Saunders","year":"2015","unstructured":"Saunders, P. M. et al. The Interaction of KIR3DL1*001 with HLA Class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope. J. Immunol. 194, 781\u2013789 (2015).","journal-title":"J. Immunol."},{"key":"67553_CR58","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41467-023-38573-8","volume":"14","author":"X Li","year":"2023","unstructured":"Li, X. et al. Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide. Nat. Commun. 14, 2929 (2023).","journal-title":"Nat. Commun."},{"key":"67553_CR59","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1136\/annrheumdis-2017-211300","volume":"76","author":"SW Scally","year":"2017","unstructured":"Scally, S. W. et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann. Rheum. Dis. 76, 1915\u20131923 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"67553_CR60","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni835","volume":"3","author":"HLE Lang","year":"2002","unstructured":"Lang, H. L. E. et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3, 940\u2013943 (2002).","journal-title":"Nat. Immunol."},{"key":"67553_CR61","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Tao, H., He, J. & Huang, S.-Y. The HDOCK server for integrated protein\u2013protein docking. Nat. Protoc. 15, 1829\u20131852 (2020).","journal-title":"Nat. Protoc."},{"key":"67553_CR62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/prot.25234","volume":"85","author":"Y Yan","year":"2017","unstructured":"Yan, Y., Wen, Z., Wang, X. & Huang, S. Addressing recent docking challenges: A hybrid strategy to integrate template-based and free protein-protein docking. Proteins 85, 497\u2013512 (2017).","journal-title":"Proteins"},{"key":"67553_CR63","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S.-Y. HDOCK: A web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy. Nucl. Acids Res. 45, W365\u2013W373 (2017).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/pro.4238","volume":"31","author":"RA Laskowski","year":"2021","unstructured":"Laskowski, R. A. & Thornton, J. M. PDBsum extras: SARS-CoV-2 and AlphaFold models. Protein Sci. 31, 283\u2013289 (2021).","journal-title":"Protein Sci."},{"key":"67553_CR65","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1080\/07391102.2020.1756411","volume":"39","author":"M Enayatkhani","year":"2020","unstructured":"Enayatkhani, M. et al. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. J. Biomol. Struct. Dyn. 39, 2857\u20132872 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"67553_CR66","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1080\/07391102.2020.1844060","volume":"40","author":"S Jyotisha Singh","year":"2020","unstructured":"Jyotisha Singh, S. & Qureshi, I. A Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches. J. Biomol. Struct. Dyn. 40, 2917\u20132933 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"67553_CR67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/07391102.2020.1792347","volume":"40","author":"A Samad","year":"2022","unstructured":"Samad, A. et al. Designing a multi-epitope vaccine against SARS-CoV-2: An immunoinformatics approach. J. Biomol. Struct. Dyn. 40, 14\u201330 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"67553_CR68","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.06.213","volume":"162","author":"I Ahammad","year":"2020","unstructured":"Ahammad, I. & Lira, S. S. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. Int. J. Biol. Macromol. 162, 820\u2013837 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"67553_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.7774\/cevr.2023.12.2.156","volume":"12","author":"LR Herrera-Ong","year":"2023","unstructured":"Herrera-Ong, L. R. Strategic construction of mRNA vaccine derived from conserved and experimentally validated epitopes of avian influenza type A virus: a reverse vaccinology approach. Clin. Exp. Vaccine Res. 12, 156 (2023).","journal-title":"Clin. Exp. Vaccine Res."},{"key":"67553_CR70","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger, E. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucl. Acids Res. 31, 3784\u20133788 (2003).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR71","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/bioinformatics\/11.6.681","volume":"11","author":"C Geourjon","year":"1995","unstructured":"Geourjon, C. & Del\u00e9age, G. SOPMA: Significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics 11, 681\u2013684 (1995).","journal-title":"Bioinformatics"},{"key":"67553_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","volume":"25","author":"C Combet","year":"2000","unstructured":"Combet, C., Blanchet, C., Geourjon, C. & Del\u00e9age, G. NPS@: Network protein sequence analysis. Trends Biochem. Sci. 25, 147\u2013150 (2000).","journal-title":"Trends Biochem. Sci."},{"key":"67553_CR73","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","volume":"16","author":"Z Du","year":"2021","unstructured":"Du, Z. et al. The trRosetta server for fast and accurate protein structure prediction. Nat. Protoc. 16, 5634\u20135651 (2021).","journal-title":"Nat. Protoc."},{"key":"67553_CR74","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo, L., Park, H. & Seok, C. GalaxyRefine: protein structure refinement driven by side-chain repacking. Nucl. Acids Res. 41, W384\u2013W388 (2013).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR75","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucl. Acids Res. 35, W407\u2013W410 (2007).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR76","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 2, 1511\u20131519 (1993).","journal-title":"Protein Sci."},{"key":"67553_CR77","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco, J. R., Aliaga, J. I., Quintana-Ort\u00ed, E. S. & Chac\u00f3n, P. iMODS: Internal coordinates normal mode analysis server. Nucl. Acids Res. 42, W271\u2013W276 (2014).","journal-title":"Nucl. Acids Res."},{"key":"67553_CR78","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","volume":"16","author":"P Rice","year":"2000","unstructured":"Rice, P., Longden, I. & Bleasby, A. EMBOSS: The European molecular biology open software suite. Trends Genet. 16, 276\u2013277 (2000).","journal-title":"Trends Genet."},{"key":"67553_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41421-023-00627-y","volume":"10","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. A framework for Frizzled-G protein coupling and implications to the PCP signaling pathways. Cell Discov. 10, 3 (2024).","journal-title":"Cell Discov."},{"key":"67553_CR80","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS ONE 5, e9862 (2010).","journal-title":"PLoS ONE"},{"key":"67553_CR81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41594-020-00542-w","volume":"28","author":"H Ishida","year":"2021","unstructured":"Ishida, H. et al. Cryo-EM structures of Toll-like receptors in complex with UNC93B1. Nat. Struct. Mol. Biol. 28, 173\u2013180 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"67553_CR82","doi-asserted-by":"publisher","first-page":"40611","DOI":"10.1074\/jbc.M112.404608","volume":"287","author":"U Ohto","year":"2012","unstructured":"Ohto, U., Yamakawa, N., Akashi-Takamura, S., Miyake, K. & Shimizu, T. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J. Biol. Chem. 287, 40611\u201340617 (2012).","journal-title":"J. Biol. Chem."},{"key":"67553_CR83","doi-asserted-by":"publisher","first-page":"729513","DOI":"10.3389\/fmolb.2021.729513","volume":"8","author":"RV Honorato","year":"2021","unstructured":"Honorato, R. V. et al. Structural biology in the clouds: The WeNMR-EOSC ecosystem. Front. Mol. Biosci. 8, 729513 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"67553_CR84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fmolb.2016.00046","volume":"3","author":"D Spiliotopoulos","year":"2016","unstructured":"Spiliotopoulos, D. et al. dMM-PBSA: A new HADDOCK scoring function for protein-peptide docking. Front. Mol. Biosci. 3, 46 (2016).","journal-title":"Front. Mol. Biosci."},{"key":"67553_CR85","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2017","unstructured":"Laskowski, R. A., Jab\u0142o\u0144ska, J., Pravda, L., Va\u0159ekov\u00e1, R. S. & Thornton, J. M. PDBsum: Structural summaries of PDB entries. Protein Sci. 27, 129\u2013134 (2017).","journal-title":"Protein Sci."},{"key":"67553_CR86","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13321-017-0254-7","volume":"9","author":"T Feng","year":"2017","unstructured":"Feng, T. et al. HawkRank: a new scoring function for protein\u2013protein docking based on weighted energy terms. J. Cheminf. 9, 66 (2017).","journal-title":"J. Cheminf."},{"key":"67553_CR87","doi-asserted-by":"publisher","first-page":"22129","DOI":"10.1039\/C6CP03670H","volume":"18","author":"F Chen","year":"2016","unstructured":"Chen, F. et al. Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 6. Capability to predict protein\u2013protein binding free energies and re-rank binding poses generated by protein\u2013protein docking. Phys. Chem. Chem. Phys. 18, 22129\u201322139 (2016).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"67553_CR88","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1039\/C4CP01388C","volume":"16","author":"H Sun","year":"2014","unstructured":"Sun, H., Li, Y., Tian, S., Xu, L. & Hou, T. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys. Chem. Chem. Phys. 16, 16719\u201316729 (2014).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"67553_CR89","doi-asserted-by":"publisher","first-page":"106729","DOI":"10.1016\/j.bioorg.2023.106729","volume":"139","author":"EM Azmy","year":"2023","unstructured":"Azmy, E. M. et al. Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations. Bioorg. Chem. 139, 106729 (2023).","journal-title":"Bioorg. Chem."},{"key":"67553_CR90","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.2147\/IDR.S362823","volume":"15","author":"SM Elhusseiny","year":"2022","unstructured":"Elhusseiny, S. M. et al. In vitro Anti SARS-CoV-2 activity and docking analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms. Infect. Drug Resist. 15, 3459\u20133475 (2022).","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"67553_CR91","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1038\/s41467-020-19025-z","volume":"11","author":"S Tojo","year":"2020","unstructured":"Tojo, S. et al. Structural analysis reveals TLR7 dynamics underlying antagonism. Nat. Commun. 11(1), 5204 (2020).","journal-title":"Nat. Commun."},{"issue":"6","key":"67553_CR92","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.jmedchem.8b01583","volume":"62","author":"L Su","year":"2019","unstructured":"Su, L. et al. Structural basis of TLR2\/TLR1 activation by the synthetic agonist diprovocim. J. Med. Chem. 62(6), 2938\u20132949 (2019).","journal-title":"J. Med. Chem."},{"issue":"2","key":"67553_CR93","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jsb.2011.12.002","volume":"177","author":"K Zhou","year":"2012","unstructured":"Zhou, K. et al. Toll-like receptor 5 forms asymmetric dimers in the absence of flagellin. J. Struct. Biol. 177(2), 402\u2013409 (2012).","journal-title":"J. Struct. Biol."},{"issue":"1","key":"67553_CR94","first-page":"e33913","volume":"15","author":"G Badoni","year":"2023","unstructured":"Badoni, G. et al. dengue burden and circulation of dengue-2 serotype among children along with clinical profiling in Uttarakhand, India: A cross-sectional study from 2018 to 2020. Cureus 15(1), e33913 (2023).","journal-title":"Cureus"},{"key":"67553_CR95","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2147\/IDR.S377252","volume":"15","author":"AM El-Kady","year":"2022","unstructured":"El-Kady, A. M. et al. Circulation of dengue virus Serotype 2 in humans and mosquitoes during an outbreak in El Quseir city, Egypt [Corrigendum]. Infect. Drug Resist. 15, 2981\u20132982 (2022).","journal-title":"Infect. Drug Resist."},{"key":"67553_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100125","volume":"20","author":"CVA Munteanu","year":"2021","unstructured":"Munteanu, C. V. A. et al. Affinity proteomics and deglycoproteomics uncover novel EDEM2 endogenous substrates and an integrative ERAD network. Mol. Cell. Proteom. 20, 100125 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"67553_CR97","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.2174\/138161209789105171","volume":"15","author":"L Stern","year":"2009","unstructured":"Stern, L. & Calvo-Calle, J. HLA-DR: Molecular insights and vaccine design. Curr. Pharm. Des. 15, 3249\u20133261 (2009).","journal-title":"Curr. Pharm. Des."},{"key":"67553_CR98","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: Signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"67553_CR99","doi-asserted-by":"publisher","first-page":"887061","DOI":"10.3389\/fimmu.2022.887061","volume":"13","author":"C Tan","year":"2022","unstructured":"Tan, C. et al. Immunoinformatics approach toward the introduction of a novel multi-epitope vaccine against Clostridium difficile. Front. Immunol. 13, 887061 (2022).","journal-title":"Front. Immunol."},{"key":"67553_CR100","doi-asserted-by":"publisher","first-page":"108515","DOI":"10.1016\/j.clim.2020.108515","volume":"218","author":"J Damoiseaux","year":"2020","unstructured":"Damoiseaux, J. The IL-2 \u2013 IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor. Clin. Immunol. 218, 108515 (2020).","journal-title":"Clin. Immunol."},{"key":"67553_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2680160","volume":"2017","author":"JL Sanchez-Trincado","year":"2017","unstructured":"Sanchez-Trincado, J. L., Gomez-Perosanz, M. & Reche, P. A. Fundamentals and methods for T- and B-cell epitope prediction. J. Immunol. Res. 2017, 1\u201314 (2017).","journal-title":"J. Immunol. Res."},{"key":"67553_CR102","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/antib4030225","volume":"4","author":"Y Kametani","year":"2015","unstructured":"Kametani, Y., Miyamoto, A., Tsuda, B. & Tokuda, Y. B Cell epitope-based vaccination therapy. Antibodies 4, 225\u2013239 (2015).","journal-title":"Antibodies"},{"key":"67553_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6718083","volume":"2018","author":"UK Adhikari","year":"2018","unstructured":"Adhikari, U. K., Tayebi, M. & Rahman, M. M. Immunoinformatics approach for epitope-based peptide vaccine design and active site prediction against polyprotein of emerging oropouche virus. J. Immunol. Res. 2018, 1\u201322 (2018).","journal-title":"J. Immunol. Res."},{"key":"67553_CR104","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1179\/2046904712Z.00000000046","volume":"32","author":"R Tapia-Conyer","year":"2012","unstructured":"Tapia-Conyer, R., Betancourt-Cravioto, M. & M\u00e9ndez-Galv\u00e1n, J. Dengue: An escalating public health problem in Latin America. Paediatr. Int. Child Health 32, 14\u201317 (2012).","journal-title":"Paediatr. Int. Child Health"},{"key":"67553_CR105","doi-asserted-by":"publisher","first-page":"678645","DOI":"10.1155\/2013\/678645","volume":"2013","author":"G A\u00f1ez","year":"2013","unstructured":"A\u00f1ez, G. & Rios, M. Dengue in the United States of America: A worsening scenario?. Biomed. Res. Int. 2013, 678645 (2013).","journal-title":"Biomed. Res. Int."},{"key":"67553_CR106","doi-asserted-by":"publisher","first-page":"10135","DOI":"10.1039\/C9CP01674K","volume":"21","author":"G Weng","year":"2019","unstructured":"Weng, G. et al. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 9. Prediction reliability of binding affinities and binding poses for protein\u2013peptide complexes. Phys. Chem. Chem. Phys. 21, 10135\u201310145 (2019).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"67553_CR107","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/molecules23081899","volume":"23","author":"T Pantsar","year":"2018","unstructured":"Pantsar, T. & Poso, A. Binding affinity via docking: Fact and fiction. Molecules 23, 1899 (2018).","journal-title":"Molecules"},{"key":"67553_CR108","doi-asserted-by":"publisher","first-page":"2311974","DOI":"10.1080\/21645515.2024.2311974","volume":"20","author":"H Daungsupawong","year":"2024","unstructured":"Daungsupawong, H. & Wiwanitkit, V. Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment. Hum. Vaccin. Immunother. 20, 2311974 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"key":"67553_CR109","doi-asserted-by":"publisher","first-page":"e0142563","DOI":"10.1371\/journal.pone.0142563","volume":"10","author":"H Ghaffari-Nazari","year":"2015","unstructured":"Ghaffari-Nazari, H. et al. Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice. PLoS ONE 10, e0142563 (2015).","journal-title":"PLoS ONE"},{"key":"67553_CR110","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.it.2016.08.007","volume":"37","author":"TW Hand","year":"2016","unstructured":"Hand, T. W. The Role of the Microbiota in Shaping Infectious Immunity. Trends Immunol. 37, 647\u2013658 (2016).","journal-title":"Trends Immunol."},{"key":"67553_CR111","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/vaccines8040635","volume":"8","author":"J Kim","year":"2020","unstructured":"Kim, J., Yang, Y. L., Jeong, Y. & Jang, Y.-S. Conjugation of human \u03b2-Defensin 2 to spike protein receptor-binding domain induces antigen-specific protective immunity against middle east respiratory syndrome coronavirus infection in human dipeptidyl peptidase 4 transgenic mice. Vaccines 8, 635 (2020).","journal-title":"Vaccines"},{"key":"67553_CR112","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1080\/07391102.2020.1850357","volume":"40","author":"VS Ayyagari","year":"2020","unstructured":"Ayyagari, V. S., C, V. T., K, A. P. & Srirama, K. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach. J. Biomol. Struct. Dyn. 40, 2963\u20132977 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"67553_CR113","doi-asserted-by":"publisher","first-page":"17617","DOI":"10.1038\/s41598-020-74091-z","volume":"10","author":"H Fu","year":"2020","unstructured":"Fu, H. et al. Codon optimization with deep learning to enhance protein expression. Sci. Rep. 10, 17617 (2020).","journal-title":"Sci. Rep."},{"key":"67553_CR114","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","volume":"5","author":"GL Rosano","year":"2014","unstructured":"Rosano, G. L. & Ceccarelli, E. A. Recombinant protein expression in Escherichia coli: Advances and challenges. Front. Microbiol. 5, 172 (2014).","journal-title":"Front. Microbiol."},{"issue":"4","key":"67553_CR115","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/biologics3040021","volume":"3","author":"SK Niazi","year":"2023","unstructured":"Niazi, S. K. & Magoola, M. Advances in Escherichia coli-based therapeutic protein expression: Mammalian conversion, continuous manufacturing, and cell-free production. Biologics 3(4), 380\u2013401 (2023).","journal-title":"Biologics"},{"key":"67553_CR116","doi-asserted-by":"publisher","first-page":"775736","DOI":"10.3389\/fmolb.2021.775736","volume":"8","author":"AA Tokmakov","year":"2021","unstructured":"Tokmakov, A. A., Kurotani, A. & Sato, K. I. Protein pI and intracellular localization. Front. Mol. Biosci. 8, 775736 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"67553_CR117","first-page":"67","volume":"284","author":"P Zhou","year":"2004","unstructured":"Zhou, P. Determining protein half-lives. Methods Mol. Biol. 284, 67\u201377 (2004).","journal-title":"Methods Mol. Biol."},{"key":"67553_CR118","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/pro.3698","volume":"28","author":"JC Aledo","year":"2019","unstructured":"Aledo, J. C. Methionine in proteins: The cinderella of the proteinogenic amino acids. Protein Sci. 28, 1785\u20131796 (2019).","journal-title":"Protein Sci."},{"key":"67553_CR119","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/protein\/4.2.155","volume":"4","author":"K Guruprasad","year":"1990","unstructured":"Guruprasad, K., Reddy, B. & Pandit, M. W. Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. Des. Sel. 4, 155\u2013161 (1990).","journal-title":"Protein Eng. Des. Sel."},{"key":"67553_CR120","doi-asserted-by":"publisher","first-page":"891","DOI":"10.6026\/97320630008891","volume":"8","author":"S Panda","year":"2012","unstructured":"Panda, S. & Chandra, G. Physicochemical characterization and functional analysis of some snake venom toxin proteins and related non-toxin proteins of other chordates. Bioinformation 8, 891\u2013896 (2012).","journal-title":"Bioinformation"},{"key":"67553_CR121","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32607\/20758251-2016-8-4-70-81","volume":"8","author":"AP Yakimov","year":"2016","unstructured":"Yakimov, A. P., Afanaseva, A. S., Khodorkovskiy, M. A. & Petukhov, M. G. Design of stable \u03b1-helical peptides and thermostable proteins in biotechnology and biomedicine. Acta. Naturae 8, 70\u201381 (2016).","journal-title":"Acta. Naturae"},{"key":"67553_CR122","doi-asserted-by":"publisher","first-page":"167696","DOI":"10.1016\/j.jmb.2022.167696","volume":"434","author":"I Dubanevics","year":"2022","unstructured":"Dubanevics, I. & McLeish, T. C. B. Optimising elastic network models for protein dynamics and allostery: Spatial and modal cut-offs and backbone stiffness. J. Mol. Biol. 434, 167696 (2022).","journal-title":"J. Mol. Biol."},{"key":"67553_CR123","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S1359-6446(05)03624-X","volume":"10","author":"PJ Hajduk","year":"2005","unstructured":"Hajduk, P. J., Huth, J. R. & Tse, C. Predicting protein druggability. Drug Discov. Today 10, 1675\u20131682 (2005).","journal-title":"Drug Discov. Today"},{"key":"67553_CR124","doi-asserted-by":"publisher","first-page":"e2000144","DOI":"10.1002\/minf.202000144","volume":"40","author":"F Barthels","year":"2020","unstructured":"Barthels, F., Schirmeister, T. & Kersten, C. BAN\u0394IT: B\u2019-factor analysis for drug design and structural biology. Mol. Inform. 40, e2000144 (2020).","journal-title":"Mol. Inform."},{"issue":"304","key":"67553_CR125","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7(304), 141 (2015).","journal-title":"Sci. Transl. Med."},{"key":"67553_CR126","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/vaccines9090946","volume":"9","author":"G Lebeau","year":"2021","unstructured":"Lebeau, G. et al. Viral Toxin NS1 implication in dengue pathogenesis making it a pivotal target in development of efficient vaccine. Vaccines 9, 946 (2021).","journal-title":"Vaccines"},{"key":"67553_CR127","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Perez-Sanchez, H., Lightstone, C. & F,. A comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr. Top. Med. Chem. 17, 1631\u20131639 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"67553_CR128","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jmb.2009.05.068","volume":"391","author":"KH DuBay","year":"2009","unstructured":"DuBay, K. H. & Geissler, P. L. Calculation of proteins\u2019 total side-chain torsional entropy and its influence on protein-ligand interactions. J. Mol. Biol. 391, 484\u2013497 (2009).","journal-title":"J. Mol. Biol."},{"issue":"2","key":"67553_CR129","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2567.2007.02651.x","volume":"122","author":"G Liu","year":"2007","unstructured":"Liu, G. & Zhao, Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122(2), 149\u2013156 (2007).","journal-title":"Immunology"},{"issue":"5","key":"67553_CR130","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2079","volume":"7","author":"LA O'Neill","year":"2007","unstructured":"O\u2019Neill, L. A. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7(5), 353\u2013364 (2007).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"67553_CR131","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180(6), 1044\u20131066 (2020).","journal-title":"Cell"},{"key":"67553_CR132","doi-asserted-by":"publisher","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan, T. et al. Toll-Like receptor signaling and its role in cell-mediated immunity. Front. Immunol. 13, 812774 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"67553_CR133","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4049\/jimmunol.182.1.55","volume":"182","author":"M McCarron","year":"2009","unstructured":"McCarron, M. & Reen, D. J. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation. J. Immun. 182(1), 55\u201362 (2009).","journal-title":"J. Immun."},{"key":"67553_CR134","doi-asserted-by":"publisher","first-page":"e34273","DOI":"10.7554\/eLife.34273","volume":"7","author":"B Webster","year":"2018","unstructured":"Webster, B. et al. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses. Elife 7, e34273 (2018).","journal-title":"Elife"},{"key":"67553_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01167-5","author":"C Ngo","year":"2024","unstructured":"Ngo, C., Garrec, C., Tomasello, E. & Dalod, M. The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond. Cell. Mol. Immunol. https:\/\/doi.org\/10.1038\/s41423-024-01167-5 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"67553_CR136","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fimmu.2014.00647","volume":"5","author":"MA Schmid","year":"2014","unstructured":"Schmid, M. A., Diamond, M. S. & Harris, E. Dendritic cells in dengue virus infection: Targets of virus replication and mediators of immunity. Front. Immunol. 5, 647 (2014).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67553-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:26:54Z","timestamp":1722428814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67553-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67553-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17645"}}